Meeting Banner
Abstract #1156

Pilot: MRI Differences Associated with Dutasteride and Finasteride Treatments in Patients with Low Risk Prostate Cancer

Olga Starobinets 1,2 , John Kornak 3 , John Kurhanewicz 1,2 , and Susan M Noworolski 1,2

1 Radiology and Biomedical Imaging, UCSF, San Francisco, CA, United States, 2 Graduate Group in Bioengineering, UC Berkeley, Berkeley, CA, United States, 3 Epidemiology and Biostatistics, UCSF, San Francisco, CA, United States

Majority of imaging parameters obtained during a prostate mpMRI scan demonstrate a better separation between low-grade cancerous and benign regions for prostate tissues exposed to anti-androgen therapy. Pretreatment with dutasteride or finasteride may facilitate a better detection of low-grade prostate cancer.

This abstract and the presentation materials are available to members only; a login is required.

Join Here